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Cognitive remediation therapy (CRT) is an increasingly implemented interven-
tion in psychiatric conditions. The majority of randomized treatment trials in
psychiatry reports cognitive improvements resulting in better functional out-
comes in CRT groups. This brief report from the national inpatient treatment
programme for eating disorders demonstrates cognitive performance task–
based improvements in patients with high and low autistic characteristics. This
preliminary study shows feasibility and benefits of individual CRT in patients
who have autism spectrum disorder features.
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Cognitive remediation therapy (CRT) aims to target ineffi-
ciencies in bigger picture thinking and cognitive flexibility
known to be cognitive maintaining factors for anorexia
nervosa (AN; Tchanturia, Giombini, Leppanen, &
Kinnaird, 2017; Tchanturia, Lounes, & Holttum, 2014).
CRT is available in individual (eight to 10) sessions and
group formats (five to six) sessions for patients with AN
(Tchanturia, Davies, Reeder, & Wykes, 2010). The positive
effects of CRT on patients with AN have been demon-
strated in both naturalistic studies and randomized control
trials (Leppanen, Adamson, & Tchanturia, 2018; Sproch,
Anderson, Sherman, Crawford, & Brandt, 2019).
Inefficiencies in cognitive flexibility (set‐shifting) and
poor Gestalt processing (central coherence) are alsot first authors.
linelibrary.com/journal/ervcommonly seen in individuals with autism spectrum dis-
orders (ASDs; Westwood, Stahl, Mandy, & Tchanturia,
2016). A feasibility study looking at individual CRT for
patients with ASD has found improvements in central
coherence but not for set‐shifting (Okuda et al., 2017).
Interestingly, there is thought to be a higher prevalence
of ASD in patients with AN (Westwood & Tchanturia,
2017). Despite the high comorbidity, there has been little
research into the way clinical symptoms of ASD impact
AN treatments. Previous research has suggested that the
presence of high ASD traits in patients with AN reduces
the effectiveness of group CRT when compared with
those with low ASD traits (Tchanturia, Larsson, &
Adamson, 2016). To date, no research has looked at the
effects of individual CRT on patients with comorbid
ASD features and AN. Therefore, this naturalistic study
aimed to examine the difference in the effects of© 2019 John Wiley & Sons, Ltd and Eating Disorders Association. 1
2 DANDIL ET AL.individual CRT treatment for adult women with AN on
an inpatient treatment programme with either high‐ or
low‐comorbid ASD characteristics.2 | METHODS
2.1 | Participants
Participants consisted of 99 females admitted to the inpa-
tient treatment programme in the specialist national eat-
ing disorder service. The inclusion criteria for the study
were adult females with a diagnosis of AN (either sub-
type) according to the Diagnostic and Statistical Manual
of Mental Disorders (Fifth Edition, DSM‐5; American
Psychiatric Association, 2013), with completed Autism
Spectrum Quotient (AQ‐10) scores and approaching their
first course of individual CRT. Only participants who
took part in individual CRT and agreed to complete the
neurocognitive measures preintervention were included
in the study. Fifty‐nine participants met the threshold
for high ASD characteristics using the AQ‐10, and the
remaining 40 participants did not meet the clinical cut‐
off for ASD. The individual CRT format consists of eight
to 10 sessions (duration of 30–40 min) shortly after the
admission, typically within the first 2 weeks. The patients
mean (M) age was 23.9 years, standard deviation (SD) of
6.2, and the mean body mass index was 14.3 (SD = 1.3)
at Time 1. At Time 2, postintervention, the mean body
mass index was 15.3 (SD = 1.4).2.2 | Procedure
All participants underwent individual CRT as described
in Tchanturia et al. (2010). Participants completed
neurocognitive measures before and after the intervention
as well as AQ‐10 on admission. Participants were drawn
from a previously analysed data set (Leppanen et al.,
2018); however, for the purposes of this study, participants
were divided according to their scores on the AQ‐10, to dif-
ferentiate ASD traits. We examined the interaction of AQ‐
10 scores with individual CRT treatment.2.3 | Measures
Both thinking styles were assessed with one performance‐
based measure and one subcategory of the self‐reported
questionnaire. The following neurocognitive features
were assessed: central coherence (“bigger picture think-
ing”), assessed with the performance‐based Rey–
Osterrieth Complex Figure (ROCF) test (Rey, 1941) and
later standardized by Osterrieth (Osterrieth, 1944) forlarge data set (Lang et al., 2016), set‐shifting measured
with the performance‐based Brixton Spatial Anticipation
Test (Burgess & Shallice, 1996) for large data set
(Tchanturia et al., 2011), cognitive rigidity, and attention
to detail measured with the self‐reported Detail and Flex-
ibility (DFlex) Questionnaire (Roberts, Barthel, Lopez,
Tchanturia, & Treasure, 2011).
The Autism Spectrum Quotient, short version (AQ‐10),
is a brief, validated measure of autistic traits, showing
equal validity to the extended version of the AQ (Allison,
Auyeung, & Baron‐Cohen, 2012). Patients completed the
AQ‐10 on admission, and using a clinical cut‐off of 6 with
higher scores indicating increased expression of ASD
traits, patients were grouped into high and low ASD traits.2.4 | Statistical analysis
To assess the impact of AQ‐10 on changes on neuropsy-
chological and self‐reported cognitive outcomes, we used
a linear mixed‐effects analysis with AQ‐10 included as a
covariate. Linear mixed‐effects analyses were conducted
using R (R Development Core Team, 2013); the effect of
time (baseline scores compared with end of treatment)
was entered as a fixed‐effect predictor. Neurocognitive
assessments (Brixton and ROCF) scores were available
from 99 and 98 participants, respectively, at baseline and
61 and 59 at the end of treatment. Self‐reported, DFlex
scores were available from 54 participants at baseline
and 34 participants at the end of treatment. A secondary
analysis was conducted using participants AQ‐10 scores
with 6 as a clinical meaningful cut‐off of high and low
scorers. Low scorers were compared with high scorers
using repeated measures ANOVA on Brixton and ROCF
scores, before and after CRT. Main effects of time and
group were computed using repeated measures ANOVA
and independent samples t tests. DFlex was not analysed
in this way due to the small sample size in each subgroup.
Secondary analysis and database management was con-
ducted using IBM's SPSS Statistics Version 24 (IBM, 2016).2.5 | Ethics
The study was approved by the hospital clinical gover-
nance committee.3 | RESULTS
3.1 | Effect of AQ‐10 on CRT outcomes
The results from the linear mixed‐effects analysis suggest
that AQ‐10 scores did not have a significant effect on
DANDIL ET AL. 3change in Brixton scores over time, F (148) = 0.036, p >
.05. Furthermore, AQ‐10 scores did not affect the rela-
tionship of DFlex, attention to detail subscale, and scores
over time, F (54) = 26.94, p > .05. However, there was a
small significant effect of AQ‐10 scores on ROCF out-
comes, F (136) = 3.93, p < .05, suggesting that AQ‐10
scores may influence the relationship between baseline
and end of treatment ROCF scores. Furthermore, a signif-
icant effect of AQ‐10 on DFlex, cognitive rigidity sub-
scale, was found, F (57) = 10.45, p < .01.FIGURE 1 Brixton score comparison at the start and end of
cognitive remediation therapy split into those that score under
and over cut‐off on the AQ‐10. ASD, autism spectrum disorder
[Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 2 Rey–Osterrieth Complex Figure (ROCF) test central
coherence scores at the start and end of cognitive remediation
therapy split into those that score under and over cut‐off on the AQ‐
10. ASD, autism spectrum disorder [Colour figure can be viewed at
wileyonlinelibrary.com]3.2 | Secondary analysis
Paired‐sample results for the 61 particpants with both
premeasure and postmeasure indicate that there was a
significant main effect of time on both Brixton scores, t
(60) = 8.57, p < .001, and ROCF central coherence, t
(58) = −2.35, p < .05, with both improving over time.
For those with complete data, 36 participants (59%)
scored below cut‐off on the AQ‐10, and 25 participants
scored above (41%). There were no significant differences
between those that scored above or below cut‐off on base-
line Brixton scores, t(97) = 0.02, p > .05, or ROCF central
cohernace scores, t(96) = 0.52, p > .05. Those that scored
below cut‐off showed a significant increase in Brixton
scores over the course of CRT, t(35) = 6.74, p < .001, with
a mean and standard deviation at the start of treatment of
12.72 (4.78) improving to 7.83 (3.31) at the end of treat-
ment. Those that scored above cut‐off on the AQ‐10 also
showed significant improvements in Brixton scores, t
(24) = 5.3, p < .001, with a mean at the start of treatment
of 14.28 (6.38) improving to 10.36 (5.76) after CRT.
Results for Brixton are displayed in Figure 1.
However, those that scored below cut‐off did not sig-
nificantly improve in central coherence on the ROCF, t
(34) = −1.44, p > .05, with a mean difference (MD)
between start and end of CRT of −0.09 (0.38). On the
other hand, although those that scored above cut‐off also
did not see a statistically significant improvement, t(23) =
−1.9, p = .06, they did see a larger MD in central coher-
ence of −0.15 (0.38). Results for the ROCF are displayed
in Figure 2.4 | DISCUSSION
In this brief naturalistic study, we have explored cognitive
test performances before and after individual CRT in
patients with high and low ASD characteristics receiving
inpatient treatment for AN. We also conducted self‐
reported measures on the same aspects of cognition: flex-
ibility and bigger picture thinking.Our results from this naturalistic observational study
demonstrated that having high ASD features had no
effect on scores in neurocognitive measures of flexibility
using the Brixton Test or the self‐reported measures of
attention to detail measured with the DFlex (Roberts
et al., 2011). However, differences were found based on
AQ‐10 scores for neurocognitive performances in bigger
picture thinking measured with the ROCF (Rey, 1941;
cited in Osterrieth, 1944) and self‐reported cognitive
rigidity using the DFlex (Roberts et al., 2011).
The results regarding the Brixton Test were in line
with previous findings of positive improvements post-
treatment in both groups (Leppanen et al., 2018). This
suggests that the presence of high ASD traits does not
impact the effects of individual CRT. Looking at the
secondary analysis, we can also see that there is an
4 DANDIL ET AL.improvement in mean scores for cognitive flexibility for
both groups. However, the ASD group starts at a more
severe point, resulting the ASD group to still appear high
at the end but not relatively to Time 1 scores (Tchanturia,
Adamson, Leppanen, & Westwood, 2019).
No effect difference was seen of AQ‐10 scores on the
self‐reported attention to detail subscale of the DFlex.
Due to the small sample sizes of the DFlex, we could
not run a secondary analysis. Therefore, it would be inter-
esting to look at this in future studies.
Small significant effects were seen in the ROCF out-
comes based on ASD traits (AQ‐10 scores). Furthermore,
our secondary analysis found that there was no signifi-
cant improvement based on the ROCF scores in central
coherence for either group, which goes against previous
research of this data set (Leppanen et al., 2018). The dif-
ferences here could be due to our analysis only being con-
ducted on patients with available AQ‐10 scores, which
has excluded 46 participants from the original data. From
Figure 2, we can see that there is a much larger spread of
data in the high ASD trait group; the sample size was very
small at 23, hence the large standard deviation. This
could be improved with a larger sample size.
A further significant effect of the AQ‐10 was found on
the self‐reported cognitive rigidity (DFlex—cognitive
rigidity subscale). This is interesting considering that
the performance‐based measure for cognitive rigidity
(the Brixton Test) was not significant. This inconsistency
between performance‐based tasks and self‐reported mea-
sures is also found between the measures of bigger pic-
ture thinking (ROCF and DFlex—attention to detail).
In support of this finding, a study conducted by Lounes,
Khan, and Tchanturia (2011) highlighted that there is
poor correspondence between the self‐report measure of
cognitive flexibility and performance on the flexibility
task; this suggests that the different measures tap into
different aspects of cognitive processing. It would be
beneficial to explore which test measures which aspect
of cognitive processing in order to best support clinical
application.
To our knowledge, this is the first report comparing
individual CRT data between patients with AN with high
and low ASD features. The naturalistic study reported in
this paper has many limitations (e.g., no randomization,
missing self‐reported data in some cases, and brief AQ‐
10 measure). However, we believe that this report is still
valuable for researchers as feasibility evidence. Future
studies would benefit from larger sample sizes, specifi-
cally in the self‐reported DFlex and in the high ASD trait
groups as well as interview‐based ASD diagnostic
measures.
In addition to the interesting research aspect, we think
that this study provides some preliminary evidence of thefeasibility of supporting patients with severe and endur-
ing AN, which have ASD comorbidity or high levels of
ASD features, and may benefit from treatment adapta-
tions. The benefits we have reported in this study suggest
that more evidence generating work in the area will be
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